… to acute leukemia, as well as the relatively long latency prior to leukemic transformation,
suggests that NHD13 requires cooperative genetic events to produce an acute leukemia. On the …

… an increased risk of acute leukemia and myelodysplastic syndromes (MDS) in persons with
… diagnosis of acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL) and MDS. A …

We reviewed the clinical features, treatment, and outcome of 100 children with myelodysplastic
syndrome (MDS), juvenile myelomonocytic leukemia (JMML), and acute myeloid …

… mutations of the N-ras gene in the DNA of the plasma, the blood cells and, when available,
the bone marrow of patients with acute myeloid leukaemia or myelodysplastic syndrome. …

… stem cells (HSCs) may be implicated in leukemia. Indeed, mice lacking Atg7 in HSCs …
resembling human myelodysplastic syndrome (MDS) progressing to acute myeloid leukemia (AML)…

… patients with acute myeloid leukaemia or myelodysplastic syndrome and Shwachman-Diamond
syndrome results from both high treatment related mortality and high disease resistance. …

… In a Phase I study of lonafarnib administered in a continuous schedule in patients with
advanced CML, MDS, CMML or acute leukemia, clinical benefit or hematological improvement …

… Some authors propose considering all patients with more than 20% of blast cells in
peripheral blood or bone marrow as having acute leukemia. Chronic myelomonocytic …

… ) from blood and marrow samples of 95 patients with various MDS subtypes and 21 patients
with acute leukemia transformed from MDS (AL-MDS). Flow cytometry revealed that a high …

Immunosuppression after organ transplantation is an acknowledged risk factor for skin cancer
and lymphoma. We examined whether there was also an excess of leukemia in patients …